About Us
Leading the Natural Regeneration Revolution in Aesthetics & Healing
We see a future where natural tissue regeneration sets the standard for medical care.
A breakthrough approach in aesthetics and healing.
Vision
To usher in a future where CXU™ technology—engineered to mirror the body’s own extracellular matrix—makes self-healing the new standard of care, so every person can regenerate, not just repair, their skin and tissue.
Mission
Conexeu develops and supplies collagen technologies that let doctors and patients regenerate tissue naturally, safely, and effectively.
We serve aesthetic clinicians, reconstructive surgeons, and the millions of people seeking alternatives to synthetic fillers or grafts.
By pairing patented, biocompatible collagen with user-friendly delivery formats, we outpace legacy fillers and skin substitutes—helping partners scale first-in-class regenerative treatments worldwide.
We are building a new class of regenerative collagen tissue products from our patented ground breaking research.
Research Driven Innovation
Built on a decade of R&D into collagen’s biological activity, Conexeu’s proprietary formulations are designed to enable faster and more complete tissue repair.
Pioneering Technology Platform
Our collagen-based scaffold platform powers multiple high-value therapeutic and aesthetic indications, representing a major leap forward in regenerative medicine.
The Time has Arrived
We are ushering in an era where collagen extracellular matrix therapies are accessible to all, reshaping the future of regenerative tissue engineering.
Investors
A Transformational Opportunity in Regenerative Medicine
Growing Market Demand.
The global shift toward safer, natural aesthetic and reconstructive solutions continues to expand.
Provisional Science.
Supported by preclinical, peer-reviewed data, Conexeu’s patented collagen approach is being investigated for applications ranging from facial rejuvenation to large-volume body contouring.
Seasoned Leadership.
World-renowned aesthetic surgeon, tissue-engineering PhDs, former CEOs/CMOs of global aesthetics leaders, and medical device veterans with proven FDA-clearance track records.
“Join Us in Shaping the Future of Regenerative Medicine”
At Conexeu, we’re not just introducing another filler or graft; we’re igniting a paradigm shift in how medicine approaches tissue restoration. From investors seeking high-growth opportunities to clinicians pursuing safer and more effective therapies—everyone benefits from a future driven by true regeneration.
Be the First to Know When We Hit Our Next Milestone
Join our newsletter to track our innovations and breakthroughs.
"*" indicates required fields